openPR Logo
Press release

Non-infectious Diarrhea Treatment Market Expansion Strategies Set to Generate Substantial Revenue in the Near Future // Atlantic Biologicals Corps, Major Pharmaceuticals, Proficient Rx LP, Chattem Inc., V.Excel International, ANI Pharmaceuticals Inc

04-30-2019 01:08 PM CET | Health & Medicine

Press release from: Fact.MR

Non-infectious Diarrhea Treatment Market Expansion

Anti-Diarrheal medications have been gaining significant traction in non-infectious diarrhea treatment market coupled with oral rehydration solution for preventing or treating loss of fluid. Although oral rehydration solution is expected to burgeon growth of Non-infectious Diarrhea Treatment Market, zinc supplementation helps in reducing severity and duration of non-infectious diarrhea treatment. Zinc supplements for non-infectious diarrhea treatment is anticipated to gain significant traction amongst caregivers and children on a larger basis. Furthermore, demand for zinc supplements in non-infectious diarrhea treatment is attracting consumer attention as it offers vital micronutrients that are essential for intestinal transport of electrolytes and water, immune function and protein synthesis.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=961

Zinc supplements are not only beneficial for non-infectious diarrhea treatment but also supports in normal development and growth of children. With advantages of zinc supplements in non-infectious diarrhea treatment, lies barriers restraining the non-infectious diarrhea treatment market on a larger basis. Dearth of acceptance of zinc supplements in non-infectious diarrhea treatment by healthcare workers and physicians is likely to restrain the growth of non-infectious diarrhea treatment market. Key players and manufacturers in non-infectious diarrhea treatment market are expected to make heavy investments in R&D for establishing optimal dosage with zinc supplements, especially for children.

Non-infectious diarrhea often lasts for a few days and results in dehydration due to the loss of fluid content in the body. It is a condition that entails at least three or more liquid or loose bowel movements within a day. It often lasts for a few days and results in dehydration due to loss in fluid content of the body. Various non-infectious causes of non-infectious diarrhea include inflammatory bowel disease, lactose intolerance, non-celiac gluten sensitivity, hyperthyroidism, irritable bowel syndrome, bile acid diarrhea and a number of medications. In most cases, stool cultures need not be studied to identify the cause. Globally, approximately 1.7- 5 billion cases of diarrhea occur every year. Non-infectious diarrhea is most common in developing countries where children get diarrhea, on an average, three times a year. Diarrhea accounted for approximately 1.26 million deaths in 2013. It is one of the most common causes of death in children younger than five years in age. Frequent episodes of diarrhea can also cause malnutrition. Other long term problems of non-infectious diarrhea include poor-intellectual development and stunted growth. Non-infectious diarrhea can be improved by sanitation and clean drinking water. Zinc tablets and Oral Rehydration Solution (ORS) - a solution with modest amounts of salts and sugar, are some of the most preferred treatments for non-infectious diarrhea. 

To know more about the Non-infectious Diarrhea Treatment Market Visit the link- https://www.factmr.com/report/961/non-infectious-diarrhea-treatment-market

The growing prevalence and recurrence of non-infectious diarrhea is expected to be a major factor driving factor for the growth of the non-infectious diarrhea treatment market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), diarrhea kills more children than malaria, measles and AIDS combined. Changes is lifestyle and eating habits are contributing to the growing prevalence of non-infectious diarrhea. The launch and addition of new products is another factor contributing to the growth of the global non-infectious diarrhea treatment market.

Non-infectious Diarrhea Treatment Market: Overview

The global market for diverticular disease therapeutics is expected to witness moderate growth over the forecast period. Majority of the products are introduced in the generic market and thus, high competition exists among local and regional players. Among the two treatment types, the anti-diarrheal medication segment is expected to lead the global non-infectious diarrhea treatment market over the forecast period. The drug store distribution channel is expected to contribute a high share in the global non-infectious diarrhea treatment market as it is the most accessible channel and majority of patients are recommended for outpatient treatment.

Non-infectious Diarrhea Treatment Market: Regional Outlook

Geographically, the global non-infectious diarrhea treatment market can be segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). Asia Pacific and Middle-East and Africa are expected to dominate the market for non-infectious diarrhea treatments, owing to the high prevalence of diarrhea. The non-infectious diarrhea treatment market in North America and Latin America is expected to grow at a significant CAGR due to the expansion of product offerings by key players. Europe is expected to hold a considerable share in the global non-infectious diarrhea treatment market throughout the forecast period.

Non-Infectious Diarrhea Treatment Market: Market Participants

The global market for diverticular disease therapeutics is highly fragmented. Examples of some of the key players operating in the global non-infectious diarrhea treatment market are Abbott Laboratories, Aidarex Pharmaceuticals LLC, Atlantic Biologicals Corps, Major Pharmaceuticals, Proficient Rx LP, Chattem Inc., V.Excel International, ANI Pharmaceuticals Inc. and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=961

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-infectious Diarrhea Treatment Market Expansion Strategies Set to Generate Substantial Revenue in the Near Future // Atlantic Biologicals Corps, Major Pharmaceuticals, Proficient Rx LP, Chattem Inc., V.Excel International, ANI Pharmaceuticals Inc here

News-ID: 1723508 • Views:

More Releases from Fact.MR

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C., Hydro Flask Lead - Fact.MR
Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics. The market
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB Ltd, ANSYS, Inc, AT&T Inc, AVEVA Group plc, Bentley Systems
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 2035
09-02-2025 | Health & Medicine
Fact.MR
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable

All 5 Releases


More Releases for Diarrhea

Why does eating too much Maltitol cause diarrhea?
Why does too much maltitol result in diarrhea? Does all sugar alcohols give you diarrhea? Are all kinds of sugar substitutes added to food healthy? Image: https://www.justgood-health.com/uploads/Erythritol2.jpgImage: https://www.justgood-health.com/uploads/Sugar-alcohol.jpg Today we're going to talk about it. What exactly is sugar alcohol? Sugar alcohols [https://www.justgood-health.com/] are polyols that are generally made from a wide range of corresponding sugars. For example, the xylose reduction is the familiar xylitol.In addition, the sugar alcohols currently under development
Traveler's Diarrhea Treatment Market Research Report 2024
The global Traveler's Diarrhea Treatment market was valued at US$ 785.4 million in 2023 and is anticipated to reach US$ 1007.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-12Y2699/Global_Traveler_s_Diarrhea_Treatment_Market_Insights_Forecast_to_2028 Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be
Understanding Traveler's Diarrhea Treatment Trends
Traveler's diarrhea is a common ailment that can disrupt travel plans and cause discomfort to millions of tourists worldwide. However, this challenge has spurred the growth of the global traveler's diarrhea treatment market, which is expected to expand significantly during the forecast period of 2024-2032. In this comprehensive guide, we will delve deeper into the market's dynamics, exploring its size, share, trends, industry segmentation, outlook, and various factors driving its
Travelers Diarrhea Treatment Market Size, Share, Growth | Report, 2026
Latest Updated Report 2023, The Global Travelers Diarrhea Treatment Market to Growing A CAGR of % during forecast period of 2023-2026. The Market is segmented by Global Travelers Diarrhea Treatment Market Breakdown by Application (Medical) by Type (General Type) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Travelers Diarrhea Treatment Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It
Carcinoid Syndrome Diarrhea Treatment Market - Increasing prevalence of rare car …
Carcinoid Syndrome Diarrhea Treatment Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Carcinoid Syndrome Diarrhea Treatment Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor
Traveler’s Diarrhea Treatment Market : Facts, Figures and Analytical Insights …
The Traveler’s Diarrhea Treatment Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed